Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Medens, IBM and ActiveHealth Management Collaborate to Transform Healthcare in Puerto Rico

November 19, 2010 4:39 am | by IBM | News | Comments

ARMONK, N.Y., Nov. 18, 2010 /PRNewswire-FirstCall/ -- In a move that will accelerate the delivery of smarter healthcare throughout Puerto Rico, IBM (NYSE: IBM), ActiveHealth Management and Medens Corporation today announced an agreement to deliver cloud services that will help physicians...

Sensor Precisely Measures Relative Humidity and Temperature

November 19, 2010 4:36 am | Product Releases | Comments

The SHT25 precisely measures relative humidity over a range of 0 to 100% RH and temperature over a range of -40 to +125°C. It achieves a typical accuracy of 1.8% RH (at 25°C) for relative humidity and ±0.2°C for temperature.

Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplasty's Urgent® PC Neuromodulation System

November 19, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Nov. 19, 2010 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Palmetto GBA for California, Nevada and Hawaii, a regional Medicare carrier,...

TOPICS:
Advertisement

Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®

November 19, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Nov. 19, 2010 /- Schizophrenia is a chronic and disabling brain disorder that affects 1 percent of the U.S. population and results in substantial medical and societal costs, in particular from use of health-care resources. It also can have devastating health-related and...

TOPICS:

VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy

November 19, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

BROOMFIELD, Colo., Nov. 19, 2010 /- Results from the VeriStrat analysis of a phase II trial of first line erlotinib in combination with sorafenib in patients with advanced non-small cell lung cancer (NSCLC) were presented today at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets in...

TOPICS:

Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference

November 19, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 19, 2010 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Piper Jaffray 22nd Annual Healthcare Conference at The New York Palace in New York City on Tuesday, November 30, at 12:30 p.m. ET.  A live audiocast of the...

TOPICS:

Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition

November 19, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., Nov. 19, 2010 /- At the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 - December 2 in Chicago, Siemens Healthcare (Booth #822, East Building/Lakeside Center, Hall D) will unveil the Biograph™ mMR*, the...

TOPICS:

System Offers Testing For Oxygen Headspace, Leak Detection, Seal Strength

November 19, 2010 4:31 am | Product Releases | Comments

MOCON Inc. is introducing the MultiCheck 300—a first-of-its-kind system that measures oxygen headspace coupled with leak detection and seal strength.

Advertisement

Spain is leading the fight against rare anemias in Europe

November 19, 2010 2:33 am | by EurekAlert | News | Comments

(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) Health care professionals and patients get together for the first time in Spain against rare anemias. One percent of couples are at risk of having a newborn who suffers a severe hemoglobin syndrome. In Spain the...

TOPICS:

Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death

November 19, 2010 1:34 am | by Boston Scientific | News | Comments

NATICK, Mass., Nov. 19, 2010 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its INCEPTA™, ENERGEN™ and PUNCTUA™ cardiac resynchronization therapy defibrillators (CRT-Ds) and impl

TOPICS:

Inspiration Biopharmaceuticals Treats First Patient in Pivotal Study of OBI-1 for Acquired Hemophilia A

November 18, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

LAGUNA NIGUEL, Calif., Nov. 19, 2010 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced the Company has initiated treatment of patients in a pivotal clinical study of OBI-1, an intravenous recombinant porcine factor VIII (FVIII) product, for the treatment of acquired...

TOPICS:

Businessman-philanthropist assists TGen-VARI study of rare cancer

November 18, 2010 10:33 pm | by EurekAlert | News | Comments

(The Translational Genomics Research Institute) International businessman and philanthropist Foster Friess has donated $50,000 to help launch a study of small cell carcinoma of the ovary by the Translational Genomics Research Institute and the Van Andel Research Institute.

TOPICS:

Light flow controlled with all-optical transistor

November 18, 2010 8:37 pm | by I-Micronews | News | Comments

By discovering how to couple light and vibrations, scientists have built a device in which a beam of light traveling through an optical microresonator could be controlled by a second, stronger light beam. The device acts like an optical transistor, in which one light beam influences the...

Fraunhofer solves power grid converter station problem

November 18, 2010 8:37 pm | by I-Micronews | News | Comments

Scientists and researchers at the Fraunhofer Institute for Integrated Systems and Device Technology (IISB) in Erlangen, Germany, said they have solved a major challenge that stumped them while building converter stations for power grids of the ...

Reports claiming ALS caused by head trauma lacks scientific validation

November 18, 2010 8:33 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A recent study suggesting that amyotrophic lateral sclerosis (ALS) may be attributed to "repetitive head trauma experienced in collision sports" lacks scientific epidemiological evidence to support this claim. In a review of the 12-patient study, several experts...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading